http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2028801-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2d2fad968a42f4254cae9e8b0f2aa48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 |
| filingDate | 1992-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba4f9abaeeb20ddad850a2ebb132847 |
| publicationDate | 1995-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2028801-C1 |
| titleOfInvention | Method of treating paralyses and epilepsies in animals |
| abstract | FIELD: veterinary. SUBSTANCE: this method prescribes perorally administering medicinal preparation of NACOM type into sick animal and determining and controlling dosage based on results of urinalysis for content of catecholamines in urine. This medicine must be administered in dose of 20 to 350 mg per animal. This preparation is indicated for treating neuro-muscular diseases of dioxyphenylamine genesis. Disclosed method further prescribes administering seduxene according to indications in grave cases. EFFECT: enhanced efficiency. |
| priorityDate | 1992-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.